Andres Leon-De

Monterrey, NLE, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults.

Journal: Blood advances

Published: July 30, 2025

Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients.

Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients.

Journal: Bone marrow transplantation

Published: October 14, 2024

The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.

The consequences of delayed diagnosis and treatment in persons with multiple sclerosis given autologous hematopoietic stem cell transplantation.

Journal: Diagnosis (Berlin, Germany)

Published: November 06, 2023

IF WE HAVE SEEN FURTHER, IT IS BY STANDING ON THE SHOULDERS OF GIANTS.

IF WE HAVE SEEN FURTHER, IT IS BY STANDING ON THE SHOULDERS OF GIANTS.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: October 05, 2021

Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients.

Splitting the Total Dose of Cyclophosphamide in Two Blocks Apart during the Conditioning of Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Results in Diminished Cardiotoxicity: Experience in 1,000 Patients.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: September 08, 2021

The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge.

The 1,000th Transplant for Multiple Sclerosis and Other Autoimmune Disorders at the HSCT-México Program: A Myriad of Experiences and Knowledge.

Journal: Frontiers in neurology

Published: December 29, 2020

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis.

Determine safety of outpatient chemotherapy and autotransplants using refrigerated, non-frozen grafts in persons with multiple sclerosis.

Journal: Clinical transplantation

Published: January 30, 2019

Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective.

Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective.

Journal: Expert review of hematology

Published: July 26, 2017

Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.

Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 26, 2016

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.

More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura.

Journal: Hematology (Amsterdam, Netherlands)

Published: February 25, 2016

Health-Related Quality of Life in leukemia Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning.

Health-Related Quality of Life in leukemia Survivors of Allogeneic Hematopoietic Stem Cell Transplantation Employing the Mexican Reduced-Intensity Conditioning.

Journal: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

Published: May 05, 2015

Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?

Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?

Journal: Transfusion

Published: July 16, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026